Historischer Abriss der molekularen Tumorforschung

  • Timm O. Goecke
  • Brigitte Royer-Pokora
Part of the Molekulare Medizin book series (MOLMED)


1866 Broca beschrieb in einer wissenschaftlichen Abhandlung mit dem Titel „Traue des tumeurs“ eine Familie mit gehäuftem Auftreten von Brust- und Leberkarzinomen (Broca 1866). Er schlug vor, dass im veränderten Gewebe eine vererbbare Aberration vorliege, die die Tumorentstehung hervorruft, womit er erstmals das Erbgut ins Zentrum des Interesses rückte.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Boveri T (1914) Zur Frage der Entstehung maligner Tumoren. Fischer, JenaGoogle Scholar
  2. Broca PP (1866) Traité des tumeurs. Asselin, ParisGoogle Scholar
  3. Bronner CE, Baker SM, Morrison PT et al. (1994) Mutation in the DNA mismatch repair gene homolog hMLH1 is as sociated with hereditary non-polyposis colon cancer. Nature 368:258–261PubMedCrossRefGoogle Scholar
  4. Call KM, Glaser T, Ito CY et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509–520PubMedCrossRefGoogle Scholar
  5. Chandrasekharappa SC, Guru SC, Manickam P et al. (1997) Positional cloning of the gene for multiple endocrine neop)asia-type 1. Science 276:404–407PubMedCrossRefGoogle Scholar
  6. Charles DR, Luce-Clausen EM (1942) The kinetics of papilloma formation in benzpyrene-treated mice. Cancer Res 2:261–263Google Scholar
  7. Cohen SN, Chang AC, Boyer HW, Helling RB (1973) Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci USA 70:3240–3244PubMedCrossRefGoogle Scholar
  8. Danna K, Nathans D (1971) Specific cleavage of simian virus 40 DNA by restriction endonuclease of Haemophilus influenzae. Proc Natl Acad Sci USA 68:2913–2917PubMedCrossRefGoogle Scholar
  9. De Klein A, Kessel A van, Grosveld G et al. (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765–767PubMedCrossRefGoogle Scholar
  10. Der CJ, Krontiris TG, Cooper GM (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79:3637–3640PubMedCrossRefGoogle Scholar
  11. Donis KH, Dou S, Chi D et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2 A and FMTC. Hum Mol Genet 2:851–856CrossRefGoogle Scholar
  12. Fishel R, Lescoe MK, Rao MRS et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027–1038PubMedCrossRefGoogle Scholar
  13. Friend SH, Horowitz JM, Gerber MR et al. (1987) Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein [published erratum appears in Proc Natl Acad Sci USA (1988) 85:2234], Proc Natl Acad Sci USA 84:9059–9063PubMedCrossRefGoogle Scholar
  14. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774–778PubMedCrossRefGoogle Scholar
  15. Groden J, Thliveris A. Samowitz W et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600PubMedCrossRefGoogle Scholar
  16. Hahn H, Wicking C, Zaphiropoulous PG et al. (1996a) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841–851PubMedCrossRefGoogle Scholar
  17. Hahn SA, Schutte M, Hoque ATMA et al, (1996b) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353PubMedCrossRefGoogle Scholar
  18. Harland M (1911) Spontaneous tumors in mice. Sci Rep Invest Imp Cancer Res Fund 4:1Google Scholar
  19. Hemminki A, MarkJe D, Tomlinson J et al. (1998) A serine/ threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184–187PubMedCrossRefGoogle Scholar
  20. Howe JR, Roth S, Rìngold JC et al. (1998) Mutations in the smad4/dpc4genein juvenilepolyposis. Science 280:1086–1088PubMedCrossRefGoogle Scholar
  21. Jackson DA, Symons RH, Berg P (1972) Biochemical method for inserting new genetic information into DNA of simian virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose Operon of Escherichia coli. Proc Natl Acad Sci USA 69:2904–2909PubMedCrossRefGoogle Scholar
  22. Jenne DE, Reimann H, Nezu J et al. (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–43PubMedCrossRefGoogle Scholar
  23. Kallioniemi A, Kallioniemi OP, Sudar D et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821PubMedCrossRefGoogle Scholar
  24. Kamb A, Gruis NA, Weaver-Feldhaus J et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436–440PubMedCrossRefGoogle Scholar
  25. Kelly TJ, Smith HO (1970) A restriction enzyme from Haemophilus influenzae. II. J Mol Biol 51:393–409PubMedCrossRefGoogle Scholar
  26. Kinzler KW, Nilbert MC, Su LK et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661PubMedCrossRefGoogle Scholar
  27. Knudson AG (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Nat Acad Sci USA 68:829–823Google Scholar
  28. Lane DP, Crawford LV (1979) Tantigen is bound to a host protein in SV40-transformed cells. Nature 278:261–263PubMedCrossRefGoogle Scholar
  29. Latif F, Tory K, Gnarra J et al. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317–1320PubMedCrossRefGoogle Scholar
  30. Leach FS, Nicolaides NC, Papadopoulos N et al. (1993) Mutation of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215–1225PubMedCrossRefGoogle Scholar
  31. Lee WH, Bookstein R, Hong F, Yoimg LJ, Shew JY, Lee EY (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235:1394–1399PubMedCrossRefGoogle Scholar
  32. Liaw D, Marsh DJ, Li J et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67PubMedCrossRefGoogle Scholar
  33. Linzer DI, Levine AJ (1979) Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43–52PubMedCrossRefGoogle Scholar
  34. Malkin D, Li FP, Strong LC et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238PubMedCrossRefGoogle Scholar
  35. Maxam AM, Gilbert W (1977) A new method for sequencing DNA. Proc Natl Acad Sci USA 74:560–564PubMedCrossRefGoogle Scholar
  36. Miki Y, Swensen J, Shattuck ED et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71PubMedCrossRefGoogle Scholar
  37. Mitelman F (1991) Catalog of chromosome aberrations in cancer, 4th edn. Wiley-Liss, New YorkGoogle Scholar
  38. Mulligan LM, Kwok JB, Healey CS et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2 A. Nature 363:458–460PubMedCrossRefGoogle Scholar
  39. Mullis KB, Faloona FA (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155:335–350PubMedCrossRefGoogle Scholar
  40. Nigro JM, Baker SJ, Preisinger AC et al. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705–708PubMedCrossRefGoogle Scholar
  41. Nowell PC, Hungerford DA (1960) A minute chromosome in human granulocytic leukemia. Science 132:1497Google Scholar
  42. Papadopoulos N, Nicolaides NC, Wei YF et al. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625–1629PubMedCrossRefGoogle Scholar
  43. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande WG (1987) Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 84:6379–6383PubMedCrossRefGoogle Scholar
  44. Perucho M, Goldfarb M, Shimizu K, Lama C, Fogh J, Wigler M (1981) Human-tum or-derived cell lines contain common and different transforming genes. Cell 79:467–476CrossRefGoogle Scholar
  45. Pinkel D, Landegent J, Collins C et al. (1988) Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci USA 85:9138–9142PubMedCrossRefGoogle Scholar
  46. Rouleau GA, Merel P, Lutchman M et al. (1993) Alteration in a new gene encoding a putative membrane-organizing proteincauses neuro-fibromatosistype2. Nature 363:515–521PubMedCrossRefGoogle Scholar
  47. Rous P (1911) A sarcoma of the fowl transmissable by an agent separable from the tumor cells. J Exp Med 13:397PubMedCrossRefGoogle Scholar
  48. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467PubMedCrossRefGoogle Scholar
  49. Schmidt L, Duh FM, Chen F et al. (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET pro to-oncogene in papillary renal carcinomas. Nat Genet 16:68–73PubMedCrossRefGoogle Scholar
  50. Shih C, Weinberg RA (1982) Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29:161–169PubMedCrossRefGoogle Scholar
  51. Takahashi M, Ritz J, Cooper GM (1985) Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42:581–588PubMedCrossRefGoogle Scholar
  52. Trent JM, Olson S, Lawn RM (1982) Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci USA 79:7809–7813PubMedCrossRefGoogle Scholar
  53. TSC Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium. Cell 75:1305–1315CrossRefGoogle Scholar
  54. Van Slegtenhorst M, De HR, Hermans C et al. (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808PubMedCrossRefGoogle Scholar
  55. Viskochil D, Buchberg AM, Xu G et al. (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187–192PubMedCrossRefGoogle Scholar
  56. Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colo rectal-tumor development. N Engl J Med 319:525–532PubMedCrossRefGoogle Scholar
  57. Wallace MR, Marchuk DA, Andersen LB et al. (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181–186PubMedCrossRefGoogle Scholar
  58. Warburg O (1926) Über den Stoffwechsel der Tumoren. Springer, BerlinGoogle Scholar
  59. Warthin AS (1913) Hereditary with reference to carcinoma. Arch Intern Med 12:546CrossRefGoogle Scholar
  60. Watson JD, Crick FHC (1953) Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature 171:737PubMedCrossRefGoogle Scholar
  61. Wooster R, Bignell G, Lancaster J et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • Timm O. Goecke
    • 1
  • Brigitte Royer-Pokora
    • 1
  1. 1.Heinrich-Heine-Universität Medizinische EinrichtungenInstitut für Humangenetik und AnthropologieDüsseldorf

Personalised recommendations